Table: begin end state 1 12 non-cytoplasmic 13 41 transmembrane 42 73 cytoplasmic 74 92 transmembrane 93 111 non-cytoplasmic 112 142 transmembrane 143 153 cytoplasmic 154 181 transmembrane 182 191 non-cytoplasmic 192 213 transmembrane 214 231 cytoplasmic 232 253 transmembrane 254 264 non-cytoplasmic 265 283 transmembrane 284 295 cytoplasmic 296 316 transmembrane 317 327 non-cytoplasmic 328 350 transmembrane 351 356 cytoplasmic 357 375 transmembrane 376 394 non-cytoplasmic 395 422 transmembrane 423 439 cytoplasmic 440 462 transmembrane 463 466 non-cytoplasmic
Input: >GFF1282 FitnessBrowser__Phaeo:GFF1282 MEPIEIGLWVSGFLLATVLLGMRVAFAAGLAGLVGLVWIFWAKFGYDPERFTKAVTIAVK TAGQVPHSKVSSQALSLIPTFILIGYLAYYAGLTKALFEAAKRWLAWVPGGLAVSTVFAT AGFAAVSGASVATSAVFARIAIPEMLKIGYDKRFAAGVVAAGGTLASLIPPSAILVIYAI IVEQDVGKLLLAGFIPGAFSAVVYGLLIIGMAMTIKGFGPAVTGFTWKERLVSLPPALPI LFVVATIILFVYNPFGGDAWGTPTEGGAIGAFVVFLMALYRGMRWAELKDALLETAKLSV MIFTIIWGVLIYVRFLGFAELPAAFSDWITSLTLSPMLILICILLAYAVLGMFMDAIGML LLTLPVVYPAVMALNGGEYVSAAESTFGMSGPMCAIWFGILVVKMAEFCLITPPIGLNCF VVAGVRDDLTVQDVFKGVTPFFIADGITIAILVAFPSIVLWLPSLA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server